Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AbGn-268 by AltruBio for Ulcerative Colitis: Likelihood of Approval
AbGn-268 is under clinical development by AltruBio and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II...
AbGn-168H by AltruBio for Graft Versus Host Disease (GVHD): Likelihood of Approval
AbGn-168H is under clinical development by AltruBio and currently in Phase I for Graft Versus Host Disease (GVHD). According to...
AbGn-268 by AltruBio for Psoriatic Arthritis: Likelihood of Approval
AbGn-268 is under clinical development by AltruBio and currently in Phase I for Psoriatic Arthritis. According to GlobalData, Phase I...